Latest Coronary catheterization Stories
BURLINGTON, Mass., Nov. 12, 2010 /PRNewswire/ -- InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced the upcoming presentation of three LipiScan(TM)-related scientific abstracts at the American Heart Association Scientific Sessions 2010 (AHA 2010), being held Nov. 13-17, 2010 at McCormick Place in Chicago. The research being presented includes an oral abstract session focused on cost effectiveness and screening...
By Rachel Champeau, UCLANew study reports on UCLA medical team's experience with new techniquesNew techniques now being used at UCLA allow doctors to more precisely target certain areas of the heart to stop ventricular arrhythmias "” serious abnormal rhythms in the heart's lower chambers "” in high-risk patients.Generally, arrhythmias can be controlled by medications, and sometimes defibrillators. But a potentially life-threatening, recurrent arrhythmia known as a ventricular tachycardia,...
TORONTO, Nov. 3, 2010 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, novel drug-coated balloon technology is being adopted in niche applications throughout Europe. This market will continue to grow as physicians increasingly use the technology in cases where other devices may not be suitable. Although drug-coated balloons lack extensive clinical data comparing their efficacy against other technologies, such as...
PALOS HEIGHTS, Ill., Oct. 27 /PRNewswire-USNewswire/ -- Interventional cardiologists affiliated with Palos Community Hospital are among the first in Chicago's southwest suburbs to embrace the transradial approach for heart angiograms and clearing blocked arteries. Transradial catheterization uses arteries in the wrist to access the heart, and it offers many improvements over the traditional approach by reducing bleeding complications, eliminating scarring and offering significantly shorter...
ST. LOUIS, Oct. 20 /PRNewswire/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that it launched the Odyssey Interventional Network, a training and educational video sharing web portal for the global cardiovascular community. The portal will showcase innovative electrophysiology (EP) and interventional cardiology (IC) procedures from leading centers around the world. The Odyssey Interventional Network utilizes Stereotaxis' state-of-the-art Odyssey technology platform to deliver a...
DALLAS, Oct. 4 /PRNewswire-USNewswire/ -- Re-opening a blocked heart artery isn't the only procedure that concerns doctors when they thread instruments through an opening in a thigh artery and into a heart artery. Closing up the thigh artery is also a concern. (Logo: http://photos.prnewswire.com/prnh/20100222/AHSALOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20100222/AHSALOGO) Arteriotomy -- the process of creating a hole in an "access artery" through which instruments are inserted --...
Researchers from the Cardiac & Vascular Institute at NYU Langone Medical Center will present at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific symposium on September 21-25, 2010 in Washington, DC. They will be available for interviews during the conference.Louis Miller, MDInterventional Cardiology Fellow, Department of Medicine, Leon H. Charney Division of Cardiology at NYU Langone Medical CenterWednesday, September 22, 2010Presenter"¢Very Long-term Clinical...
NATICK, Mass., Sept. 21 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data from its PLATINUM QCA study, which is designed to evaluate the Company's PROMUS Element(TM) Everolimus-Eluting Platinum Chromium Coronary Stent. The results provided 30-day and nine-month clinical outcomes and nine-month quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS) data supporting the safety and efficacy of the PROMUS Element Stent. Analysis of the data was...
NATICK, Mass., Sept. 14 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular Research Foundation's (CRF) 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, September 21 - 25 in Washington, D.C. "We look forward to the presentation of data from the PLATINUM QCA trial and the PERSEUS clinical program, which support the performance of our two platinum...
BURLINGTON, Mass., Sept. 1 /PRNewswire/ -- InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market the LipiScan(TM) IVUS Coronary Imaging System. LipiScan IVUS is the first cardiac catheter to combine intravascular ultrasound (IVUS) and near-infrared (NIR) spectroscopy to help cardiologists identify and...
